Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Investing.com - Cantor Fitzgerald has reiterated its Overweight rating on Cigna (NYSE:CI) with a price target of $365.00. According to InvestingPro data, analysts’ targets range from $300 to $428, with Cigna currently trading at a relatively low P/E ratio of 16.3x.
The research firm maintained its positive outlook on the health insurance company following Cigna’s exit from an Illinois county.
Cantor Fitzgerald noted that this decision aligns with Cigna’s strategic positioning statements made after the second quarter of 2025.
The firm indicated that Cigna’s county exit provides increased confidence in the company’s marketplace book for 2026.
Cantor Fitzgerald still expressed questions regarding Cigna’s reported 3% market deterioration in the second quarter of 2025, which contrasts with the 8-9% deterioration observed in data from Centene, Molina Healthcare, and Wakely.
In other recent news, Cigna Corp reported its second-quarter 2025 financial results, surpassing earnings expectations with an adjusted earnings per share of $7.20, compared to the forecast of $7.16. The company’s revenue also exceeded projections, reaching $67.2 billion against the expected $62.66 billion. Despite these positive financial results, there was a decline in Cigna’s stock, which analysts attribute to broader market concerns and specific investor reactions to the company’s operational updates and future guidance. Additionally, Guggenheim adjusted its price target for Cigna to $350 from $388, while maintaining a Buy rating on the stock. This adjustment comes after a more than 12% decline in Cigna shares since its second-quarter earnings release, compared to a decline of over 2% in the S&P 500 during the same period. Guggenheim’s decision reflects sector pressures despite Cigna’s results being in line with expectations and the company reiterating its 2025 guidance. These developments highlight the complex landscape Cigna is navigating in the current market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.